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Evidence is limited as to whether heritable risk of obesity varies
throughout adulthood. Among .34,000 European Americans,
aged 18–100 years, from multiple U.S. studies in the Population
Architecture using Genomics and Epidemiology (PAGE) Consor-
tium, we examined evidence for heterogeneity in the associations
of ﬁve established obesity risk variants (near FTO, GNPDA2,
MTCH2, TMEM18, and NEGR1) with BMI across four distinct
epochs of adulthood: 1) young adulthood (ages 18–25 years),
adulthood (ages 26–49 years), middle-age adulthood (ages 50–
69 years), and older adulthood (ages $70 years); or 2)b ym e n o -
pausal status in women and stratiﬁcation by age 50 years in men.
Summary-effect estimates from each meta-analysis were com-
pared for heterogeneity across the life epochs. We found hetero-
geneity in the association of the FTO (rs8050136) variant with
BMI across the four adulthood epochs (P = 0.0006), with larger
effects in young adults relative to older adults (b [SE] = 1.17
[0.45] vs. 0.09 [0.09] kg/m
2, respectively, per A allele) and smaller
intermediate effects. We found no evidence for heterogeneity in
the association of GNPDA2, MTCH2, TMEM18, and NEGR1 with
BMI across adulthood. Genetic predisposition to obesity may
have greater effects on body weight in young compared with
older adulthood for FTO, suggesting changes by age, generation,
or secular trends. Future research should compare and contrast
our ﬁndings with results using longitudinal data. Diabetes
62:1763–1767, 2013
I
n the past 5 years, genome-wide association studies
have identiﬁed common genetic loci associated with
BMI (in kilograms per meters squared) mainly in
European populations (1–4). It has been suggested
that genetic effects of BMI risk variants vary by age (1–7).
However, most studies about age-varying effects have fo-
cused on childhood and adolescence or contrasted these
developmental periods to adulthood (3–8). While it is
known that adulthood weight changes are substantial, with
weight gain common in earlier to mid-age adulthood and
unintentional weight loss in later adulthood, evidence is
limited for any differences in the heritable variation of
weight across the transition from young adulthood to
older adulthood. A few studies have begun to interrogate
the importance of genetic susceptibility variants across the
life course, using both cross-sectional and longitudinal
designs, but only for a limited number of genetic variants
(6,7,9)—for example, for FTO and MC4R. Studies of BMI
susceptibility variants during childhood (0–18/20 years)
are the most common (other than middle-aged adults) and,
using cross-sectional data, have shown mixed results (3–
8). A few cross-sectional studies over shorter periods of
the life cycle suggest a stronger genetic association during
childhood or adolescence compared with middle-aged
adults (5,8). Two longitudinal studies have shown larger
effect estimates for FTO around late adolescence and
young adulthood compared with childhood (6,7) or be-
yond young adulthood (7). There have been few life-course
studies of distinct genetic effects operating across adult-
hood (20–90 years) within large population-based samples,
and for the most part, little difference in BMI has been
associated with genetic variants (10).
In our previous work in the Population Architecture
using Genomics and Epidemiology (PAGE) Study, we
replicated the effects of genome-wide association studies
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BRIEF REPORTobesity risk variants on adult BMI, in particular for ﬁve
single nucleotide polymorphisms (SNPs) near FTO and
one SNP near each of MC4R, TMEM18, GNPDA2, NEGR1,
and MTCH2 (11). This sample of European American
individuals ranged from 18–100 years of age, spanning the
life course from young adulthood (ages 18–25 years),
a period with increased risk of weight gain (12), to older
adulthood (age $70 years), a period of declining steroid
hormone levels, loss of lean body mass, and abdominal fat
accumulation (13,14). For the current study, we in-
terrogated the evidence for heterogeneity of genetic
effects in ﬁve of six previously replicated obesity loci by
contrasting cross-sectional associations across four age
groups within PAGE: young adulthood (ages 18–25 years),
adulthood (ages 26–49 years), middle-age adulthood (ages
50–69 years), and older adulthood (ages $70 years). We
also examined whether observed genetic effects differed
in females according to menopausal status during a period
in the life course associated with increased risk of weight
gain and obesity (15). Similarly, we investigated genetic
effects among men stratiﬁed by age 50 years (i.e., ,50 or
$50 years) as a comparison with age at onset of meno-
pause in women and to consider the potential impact
of declining testosterone levels in males associated with
aging (16).
RESEARCH DESIGN AND METHODS
Study populations. PAGE involves several studies, described in detail else-
where (17) and on the PAGE Web site (https://www.pagestudy.org). Brieﬂy,
the PAGE Study consists of four sites: Genetic Epidemiology of Causal Var-
iants Across the Life Course Consortium, Epidemiologic Architecture of Genes
Linked to Environment (EAGLE), Multiethnic Cohort (MEC), and Women’s
Health Initiative (WHI). From the Genetic Epidemiology of Causal Variants
Across the Life Course Consortium, we used European Americans from the
Atherosclerosis Risk in Communities, Coronary Artery Risk Development in
Young Adults, and Cardiovascular Health Studies with men and women from
diverse regions in the U.S., ranging in age from childhood to advanced age.
EAGLE is based on three National Health and Nutrition Examination Surveys
with information on demographics, phenotypes, and environmental expo-
sures. MEC contains ﬁve major ethnic groups of older men and women in
Hawaii and California. WHI contains postmenopausal women who have been
genotyped.
European ancestry was self-reported and conﬁrmed using ancestry in-
formative markers in majority of study samples as described previously (11,18).
Underweight (BMI ,18.5 kg/m
2) and extremely overweight (BMI .70 kg/m
2)
individuals were excluded for all PAGE sites, because they could be attributed
to illness, a rare mutation associated with obesity, or data-coding errors. After
applying the above exclusion criteria, our sample included 34,053 participants
of European descent from the PAGE consortium. Sample size, age, and BMI
for men and women by study cohort for each life epoch are provided in
Supplementary Table 1.
Anthropometric measurements. In MEC, self-reported height and weight
were used to calculate baseline BMI (calculated as weight [kg]/height [m
2]).
Multiple studies have described systematic biases in self-reported compared
with measured height and weight; yet in general, these differences are small
(,1.0 kg/m
2) and unlikely to affect any conclusions drawn from analyses using
self-reported data (19,20). At all other sites, BMI was calculated from height
and weight measured at study enrollment in a clinic setting, with the exception
of 140 WHI subjects whose ﬁrst available measurements were collected 1 or 3
years after enrollment. Each participant contributed one cross-sectional ob-
servation for height and weight within one of the four life-cycle periods of
study.
SNP selection and genotyping. For ﬁve of the six loci (FTO, TMEM18,
GNPDA2, NEGR1, and MTCH2) previously associated with BMI in the Eu-
ropean Americans of the PAGE study, SNPs were available for individuals
across four periods of adulthood: 1) young adulthood, between age 18 and 25
years; 2) adulthood, between ages 26 and 50 years; 3) middle-age adulthood,
between ages 51 and 70 years; and 4) older adulthood, between ages 71 and
100 years. The SNPs at the ﬁve loci included the following: rs10838938 (near
MTCH2), rs10938397 (near GNDPA2), rs2815752 (near NEGR1), rs6548238
(near TMEM18), and rs8050136 (near FTO). We did not include rs12970134
(near MC4R) because it was not available for individuals ,50 years of age,
thus limiting comparisons across life epochs. Each PAGE site used different
genotyping platforms, with similar quality-control criteria as described pre-
viously (11). All sites used appropriate internal and external controls and
excluded SNPs deviating from Hardy-Weinberg expectations or with low
concordance (typically ,95–99%).
Statistical analysis. BMI was natural-log transformed prior to analysis to
stabilize the variances and improve normality assumptions Each cohort esti-
mated the association between each SNP and BMI using linear regression with
robust SEs, assuming an additive genetic model. All analyses were stratiﬁed by
sex and life epoch of adulthood or for the secondary analyses by menopausal
status in women or stratiﬁed by age 50 years in men. Models were adjusted for
10 principal components calculated from ancestry informative markers, study
center or clinic, age, current smoking (yes or no), and the possible correlation
among family members recruited within a subset of studies. Ancestry-speciﬁc
linkage disequilibrium patterns were compared forselected SNPs in HaploView
4.2 (Broad Institute, Cambridge, MA) (17) using data from the International
HapMap Project (Version 3, Release R2) (21).
Meta-analysis.Toprovidecombinedsummary measuresacross lifeepochand
sex, effect estimates for BMI–SNP associations from each cohort were meta-
analyzed separately by life epoch and sex using the inverse variance–weighted
method. Using meta-regression, we tested summary effect estimates for BMI–
SNP associations across each life epoch for heterogeneity with a signiﬁcance
level of P , 0.05 (Bonferroni correction for testing ﬁve loci was P , 0.01).
A similar strategy was used for meta-analyses of menopausal status and age
among men (i.e., ,50 or $50 years). Results from BMI–SNP associations were
meta-analyzed across all cohorts by menopausal status in women and stratiﬁed
by age 50 years in men. Using meta-regression, we tested for heterogeneity of
effect estimates between pre- and postmenopausal women and ,50- or $50-
year-old men. We used METAL software for all meta-analyses with the inverse
variance–weighted method (22).
RESULTS
Table 1 provides a description of the study population age
and BMI. Supplementary Table 1 shows mean age and BMI
TABLE 1
Demographic characteristics of European American PAGE participants by life epoch
Sex Life epoch N Mean age (years) SD (age) Mean BMI SD (BMI)
Male and female 18–25 years 1,382 22.31 2.07 24.63 4.53
26–49 years 5,544 39.46 3.54 26.59 5.15
50–69 years 18,006 59.75 4.81 28.77 5.92
$70 years 9,121 74.44 3.58 27.35 5.14
Female Premenopausal 4,186 38.87 6.41 26.02 5.60
Menopausal 19,723 64.74 7.33 28.85 6.45
Male Age ,50 years 2,282 37.69 6.53 27.31 5.58
Age $50 years 7,724 58.93 6.05 26.98 4.04
All 18–70+ years 34,053 58.86 4.16 27.87 5.53
Included cohorts: Atherosclerosis Risk in Communities Study, Coronary Artery Risk in Young Adults, Cardiovascular Health Study, EAGLE,
MEC, and WHI. Minimum BMI was 18.5 for all sites and ancestry groups.
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adults ages 18–25 years (24.6 kg/m
2) and highest in adults
between 50 and 69 years of age (28.8 kg/m
2). In older
adults (aged $70 years), the mean BMI was lower at 27.4
kg/m
2. Premenopausal women had a lower BMI than
postmenopausal women: 26.02 and 27.31 kg/m
2, respec-
tively. BMI was similar between men aged ,50 (27.31 kg/m
2)
and $50 years (26.98 kg/m
2).
Associations and heterogeneity for BMI across the four
life epochs with each of the ﬁve SNPs are shown in Table
2, Fig. 1, and Supplementary Table 2. Allele frequencies for
each SNP are presented for the whole sample because
they differed little by life epoch. The association of BMI
with four of the ﬁve loci—TMEM18, GNPDA2, NEGR1,
and MTCH2—did not signiﬁcantly differ across the four
life epochs (heterogeneity P . 0.05) in men and women
combined or stratiﬁed by sex. We found evidence for
heterogeneity in the effect estimate for the association
between BMI and FTO SNP (rs8050136) for men and
women together (P = 0.0006) (Table 2) and separately in
men (P = 0.01) with a tendency in women (P = 0.08)
(Supplementary Table 2). The largest effect was seen for
young adults (ages 18–25 years: b [SE] = 1.17 [0.45] kg/m
2
per risk allele) epoch and smaller in each successive life
epoch with no effect in adults $70 years (b [SE] = 0.09
[0.09] kg/m
2 per risk allele). We found no evidence that the
distinct FTO genetic effects across the life course for BMI
were speciﬁcally related to menopausal status in women
(Supplementary Table 3) or differed in men around the
comparable age cutoff of 50 years, although the effect size
was larger in premenopausal compared with menopausal
women and in men aged ,50 years compared with men
aged $50 years due to the overall trend across the four
epochs.
DISCUSSION
Using ﬁve loci previously associated with BMI in adults (1–
3) and replicated in our study population (11), we evalu-
ated evidence for heterogeneity of the associations with
BMI across four distinct phases of adulthood: young
adulthood (ages 18–25 years), adulthood (ages 26–49
years), middle-aged adulthood (ages 50–69 years), and older
adulthood (ages $70 years) using the 34,053 European
Americans in the PAGE study. In addition, we conducted
secondary analyses that considered whether BMI–SNP
associations differed according to menopausal status in
women or age 50 years in men.
In this cross-sectional analysis, we found evidence of
heterogeneity in the BMI–SNP associations across life
epochs for rs8050136 (FTO), with effect estimates that
TABLE 2
Effect estimates for BMI–SNP associations across life epoch in men and women combined and tested for interaction with x
2 for
heterogenity (Phet , 0.05)
SNP Gene
Effect/
other
allele Sex Life epoch (age) N EAF
b (kg/m
2)
per
allele
SE
(kg/m
2)
per
allele P value
Difference
across four
life epochs
x
2
het Phet
rs10838738 MTCH2 A/G Male and
female
All ages (18–70+ years) 22,589 0.65 20.142 0.056 0.01 0.71 0.87
18–25 years 1,055 20.218 0.166
26–49 years 2,242 20.053 0.136
50–69 years 11,456 20.158 0.089
$70 years 7,836 20.136 0.096
rs10938397 GNDPA2 A/G Male and
female
All ages (18–70+ years) 19,276 0.56 20.122 0.064 0.06 5.43 0.14
18–25 years 1,052 0.002 0.161
26–49 years 2,256 0.088 0.131
50–69 years 10,201 20.283 0.101
$70 years 5,767 20.104 0.129
rs2815752 NEGR1 T/C Male and
female
All ages (18–70+ years) 29,464 0.63 0.106 0.045 0.02 0.38 0.95
18–25 years 1,061 0.188 0.163
26–49 years 4,102 0.104 0.096
50–69 years 16,465 0.107 0.063
$70 years 7,836 0.085 0.093
rs6548238 TMEM18 T/C Male and
female
All ages (18–70+ years) 30,298 0.17 20.244 0.056 1.54E-05 2.25 0.52
18–25 years 1,066 20.393 0.215
26–49 years 4,043 20.141 0.125
50–69 years 16,490 20.309 0.084
$70 years 8,699 20.164 0.107
rs8050136 FTO A/C Male and
female
All ages (18–70+ years) 27,652 0.40 0.384 0.047 8.61E-16 17.53 5.49E-04
18–25 years 246 1.173 0.450
26–49 years 3,080 0.621 0.120
50–69 years 16,481 0.444 0.063
$70 years 7,845 0.090 0.093
EAF, frequency of effect allele; Phet, P value for x
2 test of heterogeneity; x
2
het, x
2 value for test of heterogeneity across age groups.
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life epoch of adulthood. We did not ﬁnd any statistically
signiﬁcant evidence of an interaction for the FTO variant
and menopausal status, suggesting that our ﬁndings are
not related to hormonal changes that occur at menopause.
However, the trend for effect sizes is consistent with age-
group comparison showing the larger effect sizes in pre-
menopausal women and men aged ,50 years compared
with the older women and men. These results suggest that
FTO genotype has a comparatively stronger association
with BMI in young to middle-aged adulthood relative to
older adulthood, in which no effect was seen. It is possible
that at older ages, genetic and physiological processes
related to aging might bear greater inﬂuence on BMI. In
addition, it is likely that environmental factors play
a comparatively stronger role in shaping BMI or have
a comparatively longer period to inﬂuence BMI earlier in
the life cycle. It is also possible that cohort differences,
which we do not directly address in our analysis, have
differential inﬂuence on BMI in our sample. Our ﬁndings
for differences in genetic effects by life epoch for FTO
may suggest changes by age, secular or generational
differences, or a combination of these which we cannot
address in this study.
Our ﬁndings of genotype-by-life-course interaction for
FTO are part of a growing literature suggestive of varying
genetic effects for FTO across the life course, with studies
pointing to stronger associations in adolescence and
young adulthood compared with childhood (6,7) or mid-
dle-aged adulthood (7,8). A recent study that examined
associations of FTO variants with BMI across the life
course (birth to age 53 years) in a 1946 birth cohort found
comparatively stronger associations in adolescence and
young adulthood compared with childhood or beyond the
young adult years (7). Results from a cross-sectional study
in suggested larger effect sizes for FTO and other BMI
susceptibility loci in adolescents compared with middle-
aged adults (8). Still another study reported larger genetic
effects for the BMI–FTO association at age 17 years (ad-
olescence) compared with age 8 years (childhood) in non-
Hispanic white children (6). In contrast to our study ﬁndings,
a new study of European adults, aged 20–90 years, did not
ﬁnd a FTO-by-age interaction with cross-sectional BMI
(10). However, the youngest and oldest individuals were
FIG. 1. A–E: Effect estimates (b [95% CI]) across life epoch in men and women combined and tested for interaction with x
2 for heterogeneity
(P value for x
2 test of heterogeneity <0.05). (A high-quality color representation of this ﬁgure is available in the online issue.)
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study.
No other interactions across life epoch were noted. The
other loci considered in this paper have been associated
with obesity in adult Caucasians (1–3) and, with the ex-
ception of MTCH2, in children (3,5–7). As FTO is well-
known to display the largest magnitude of effect on BMI
across populations, it is not completely unexpected that
only FTO demonstrates a statistically signiﬁcant genotype-
by-life-course interaction. Indeed, we may have had lim-
ited power to detect interaction effects for the other ﬁve
variants interrogated, as their effect sizes with BMI are
smaller and therefore harder to detect. Further study in
larger populations of individuals and with more of the well-
established BMI loci are warranted.
Our study sample, particularly for the young adult and
older adult age groups, limits our ability to provide robust
estimates in sex-stratiﬁed analyses and detect smaller
differences between effect estimates that may indeed be
present. For FTO, we are unable to evaluate why effect
sizes may vary across life epochs but can speculate that
the underlying genetic predisposition to obesity may at-
tenuate, as body weight is increasingly determined by
other genetic and cumulative environmental exposures.
Indeed, the contribution of behavioral and environmental
factors directly and indirectly by inﬂuencing genetic con-
tributions on body weight across phases of adulthood are
valid scientiﬁc questions in understanding changes to
heritability of body weight over the life course. For ex-
ample, a few studies have found that the association be-
tween FTO and BMI varies according to physical activity
levels (23,24) and dietary intake (25,26).
Using longitudinal data that span life epochs will be
helpful in further understanding the role of genes in de-
velopmental trajectories across the life course, trajectories
that may operate at an optimal rate within a particular
window, among speciﬁc genotypes and speciﬁc environ-
mental contexts.
ACKNOWLEDGMENTS
No potential conﬂicts of interest relevant to this article
were reported.
M.G. wrote the manuscript, contributed individual co-
hort analyses, and conducted meta-analyses. P.G.-L. and
S.V. wrote the manuscript. U.L., J.H.F., M.F., M.D.R., S.B.,
T.C.M., D.C.C., U.P., and K.E.N. wrote the manuscript and
contributed individual cohort analyses. S.-A.L. contributed
individual cohort analyses and conducted meta-analyses.
L.R.W., R.L.P., J.P., K.M., J.E.M., L.L.M., L.H.K., L.N.K.,
C.P.H., B.E.H., J.H., M.D.G., R.G., N.F., C.S.C., P.B., L.A.H.,
and C.A.H. contributed individual cohort analyses. K.E.N.
is the guarantor of this work and, as such, had full access
to all the data in the study and takes responsibility for the
integrity of the data and the accuracy of the data analysis.
REFERENCES
1. Speliotes EK, Willer CJ, Berndt SI, et al.; MAGIC; Procardis Consortium.
Association analyses of 249,796 individuals reveal 18 new loci associated
with body mass index. Nat Genet 2010;42:937–948
2. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide asso-
ciation yields new sequence variants at seven loci that associate with
measures of obesity. Nat Genet 2009;41:18–24
3. Willer CJ, Speliotes EK, Loos RJ, et al.; Wellcome Trust Case Control
Consortium; Genetic Investigation of ANthropometric Traits Consortium.
Six new loci associated with body mass index highlight a neuronal in-
ﬂuence on body weight regulation. Nat Genet 2009;41:25–34
4. Zhao J, Bradﬁeld JP, Zhang H, et al. Role of BMI-associated loci identiﬁed
in GWAS meta-analyses in the context of common childhood obesity in
European Americans. Obesity (Silver Spring) 2011;19:2436–2439
5. den Hoed M, Ekelund U, Brage S, et al. Genetic susceptibility to obesity
and related traits in childhood and adolescence: inﬂuence of loci identiﬁed
by genome-wide association studies. Diabetes 2010;59:2980–2988
6. Hallman DM, Friedel VC, Eissa MA, et al. The association of variants in the
FTO gene with longitudinal body mass index proﬁles in non-Hispanic
white children and adolescents. Int J Obes (Lond) 2012;36:61–68
7. Hardy R, Wills AK, Wong A, et al. Life course variations in the associations
between FTO and MC4R gene variants and body size. Hum Mol Genet
2010;19:545–552
8. Graff M, North KE, Mohlke KL, et al. Estimation of genetic effects on BMI
during adolescence in an ethnically diverse cohort: The National Longi-
tudinal Study of Adolescent Health. Nutr Diabetes 2012;2:e47
9. Liu G, Zhu H, Dong Y, Podolsky RH, Treiber FA, Snieder H. Inﬂuence of
common variants in FTO and near INSIG2 and MC4R on growth curves for
adiposity in African- and European-American youth. Eur J Epidemiol 2011;
26:463–473
10. Hertel JK, Johansson S, Sonestedt E, et al. FTO, type 2 diabetes, and
weight gain throughout adult life: a meta-analysis of 41,504 subjects from
the Scandinavian HUNT, MDC, and MPP studies. Diabetes 2011;60:1637–
1644
11. Fesinmeyer MD, North KE, Ritchie MD, et al. Genetic risk factors for BMI
and obesity in an ethnically diverse population: results from the Pop-
ulation Architecture using Genomics and Epidemiology (PAGE) Study.
Obesity (Silver Spring). 22 June 2012 [Epub ahead of print]
12. Gordon-Larsen P, Adair LS, Nelson MC, Popkin BM. Five-year obesity in-
cidence in the transition period between adolescence and adulthood: the
National Longitudinal Study of Adolescent Health. Am J Clin Nutr 2004;80:
569–575
13. Brockmann GA, Tsaih SW, Neuschl C, Churchill GA, Li R. Genetic factors
contributing to obesity and body weight can act through mechanisms af-
fecting muscle weight, fat weight, or both. Physiol Genomics 2009;36:114–
126
14. Goldspink G. Loss of muscle strength during aging studied at the gene
level. Rejuvenation Res 2007;10:397–405
15. St-Onge M-P, Bjorntorp P. Hormonal inﬂuences on human body compo-
sition. In Human Body Composition. Heymsﬁeld S, et al, Eds. Champaign,
Human Kinetics, 2005, p. 331–340
16. Svartberg J. Epidemiology: testosterone and the metabolic syndrome. Int J
Impot Res 2007;19:124–128
17. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization
of LD and haplotype maps. Bioinformatics 2005;21:263–265
18. Matise TC, Ambite JL, Buyske S, et al.; PAGE Study. The Next PAGE in
understanding complex traits: design for the analysis of Population Ar-
chitecture Using Genetics and Epidemiology (PAGE) Study. Am J Epi-
demiol 2011;174:849–859
19. Bes-Rastrollo M, Sabaté J, Jaceldo-Siegl K, Fraser GE. Validation of self-
reported anthropometrics in the Adventist Health Study 2. BMC Public
Health 2011;11:213
20. Gorber SC, Tremblay MS. The bias in self-reported obesity from 1976 to
2005: a Canada-US comparison. Obesity (Silver Spring) 2010;18:354–361
21. The International HapMap Consortium. The International HapMap Project.
Nature 2003;426:789–796
22. Willer CJ, Li Y, Abecasis GR. METAL: fast and efﬁcient meta-analysis of
genomewide association scans. Bioinformatics 2010;26:2190–2191
23. Kilpeläinen TO, Qi L, Brage S, et al. Physical activity attenuates the in-
ﬂuence of FTO variants on obesity risk: a meta-analysis of 218,166 adults
and 19,268 children. PLoS Med 2011;8:e1001116
24. Rampersaud E, Mitchell BD, Pollin TI, et al. Physical activity and the as-
sociation of common FTO gene variants with body mass index and obesity.
Arch Intern Med 2008;168:1791–1797
25. Corella D, Arnett DK, Tucker KL, et al. A high intake of saturated fatty acids
strengthens the association between the fat mass and obesity-associated
gene and BMI. J Nutr 2011;141:2219–2225
26. Lappalainen T, Lindström J, Paananen J, et al. Association of the fat mass
and obesity-associated (FTO) gene variant (rs9939609) with dietary intake
in the Finnish Diabetes Prevention Study. Br J Nutr 2012;108:1859–1865
M. GRAFF AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 62, MAY 2013 1767